Hiromitsu Kumada - Department of Hepatology, Toranomon Hospital

基本信息

浏览量：19

职业迁徙

个人简介

Hiromitsu Kumada's Expert Impact Concepts for which Hiromitsu Kumada has direct influence: Chronic hepatitis , Hepatocellular carcinoma , Combination therapy , Hepatitis virus , Japanese patients , Hcv genotype , Interferon therapy. Hiromitsu Kumada's KOL impact Concepts related to the work of other authors for which Hiromitsu Kumada has influence: Hepatocellular carcinoma , Chronic hepatitis , Liver disease , Antiviral therapy , Hcc patients , Hcv infection.

研究兴趣

论文共 794 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Higher Level of Hepatitis B Surface Antigen Associated with Delayed Development of Hepatocellular Carcinoma in Immune-Tolerant Patients

Tai-Chung Tseng,Tetsuya Hosaka, Mei-Hung Pan,Chun-Jen Liu,Fumitaka Suzuki, Chien-Jen Chen,Tung-Hung Su,Hiromitsu Kumada, Wan-Ting Yang, Hung-Chih Yang,Chen-Hua Liu, Pei-Jer Chen, Hwai-I Yang, Jia-Horng Kao

Hepatology (Baltimore, Md) (2025)

引用0浏览0WOS引用

Transarterial Chemoembolisation Combined with Lenvatinib Plus Pembrolizumab Versus Dual Placebo for Unresectable, Non-Metastatic Hepatocellular Carcinoma (LEAP-012): a Multicentre, Randomised, Double-Blind, Phase 3 Study